BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6802927)

  • 1. Frequency of B lymphocytes responsive to anti-immunoglobulin.
    Defranco AL; Raveche ES; Asofsky R; Paul WE
    J Exp Med; 1982 May; 155(5):1523-36. PubMed ID: 6802927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocyte subpopulation defined by a rat monoclonal antibody, 14G8.
    Kung JT; Sharrow SO; Ahmed A; Habbersett R; Scher I; Paul WE
    J Immunol; 1982 May; 128(5):2049-56. PubMed ID: 6801129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
    Muraguchi A; Butler JL; Kehrl JH; Fauci AS
    J Exp Med; 1983 Feb; 157(2):530-46. PubMed ID: 6401797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of growth and proliferation in B cell subpopulations.
    DeFranco AL; Kung JT; Paul WE
    Immunol Rev; 1982; 64():161-82. PubMed ID: 6806172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human b-cell differentiation. I. Analysis of immunoglobulin heavy chain switching using monoclonal anti-immunoglobulin M, G, and A antibodies and pokeweed mitogen-induced plasma cell differentiation.
    Kuritani T; Cooper MD
    J Exp Med; 1982 Mar; 155(3):839-51. PubMed ID: 6801181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.
    Boyd AW; Pike BL
    Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
    Phillips NE; Parker DC
    J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
    Nossal GJ; Pike BL; Battye FL
    Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes.
    Sieckmann DG; Scher I; Asofsky R; Mosier DE; Paul WE
    J Exp Med; 1978 Dec; 148(6):1628-43. PubMed ID: 102729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
    Chen-Bettecken U; Wecker E; Schimpl A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7384-8. PubMed ID: 3933005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mouse lymphocytes by anti-immunoglobulin. IV. Stimulation with soluble heterologous anti-delta antibodies.
    Sieckmann DG; Finkelman FD; Thompson CB; Scher I
    Cell Immunol; 1984 Apr; 85(1):1-14. PubMed ID: 6424947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT; Naides SJ; Benacerraf B; Sy MS
    J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assay for the quantitative inhibition of anti-immunoglobulin antibodies performed at the cell surface. Studies with anti-kappa and anti-mu chain antibodies.
    Stanislawski M; Mitard M; Harel A
    Mol Immunol; 1979 May; 16(5):317-26. PubMed ID: 114751
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of B-lymphocyte transformation by Epstein-Barr virus decreases with entry into the cell cycle.
    Roome AJ; Reading CL
    Immunology; 1987 Feb; 60(2):195-201. PubMed ID: 3028939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu.
    Kuruganti U; Henderson LA; Garner RE; Asofsky R; Baker PJ; Domer JE
    J Leukoc Biol; 1988 Nov; 44(5):422-33. PubMed ID: 3141542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes.
    Kim KJ; Rollwagen F; Asofsky R; Lefkovits I
    Eur J Immunol; 1984 May; 14(5):476-82. PubMed ID: 6233161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation.
    Kearse KP; Cassatt DR; Kaplan AM; Cohen DA
    J Immunol; 1988 Mar; 140(6):1770-8. PubMed ID: 3126236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of murine B cells: the role of surface immunoglobulins.
    Vitetta E; Puré E; Isakson P; Buck L; Uhr J
    Immunol Rev; 1980; 52():211-31. PubMed ID: 6790419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.